Altstätten, March 19, 2020 - COLTENE Holding AG confirms that the Annual General Meeting scheduled for April 2, 2020 will be held under strict conditions.
In accordance with Ordinance 2 on Measures to Combat the Corona Virus (COVID-19) of the Swiss Federal Council as amended on March 16, 2020, the shareholders of COLTENE Holding AG are not permitted to attend the Annual General Meeting in person. Instead, they are requested by the Board of Directors to exercise their rights at the Annual General Meeting by instructing the independent proxy. For this reason, the voting period will be extended until April 1, 2020.
If you have any questions regarding the agenda of the Annual General Meeting, please contact the company directly.
For further information: Gerhard Mahrle, CFO,
Phone +41 71 757 54 37, Mobile +41 79 346 23 02, E-Mail email@example.com
To receive the latest information on COLTENE Holding AG on a regular basis, please register at www.coltene.com
Background information on COLTENE
COLTENE is an international company for the development, production and distribution of dental consumables and small devices in the areas of infection control, tooth preservation and treatment efficiency. COLTENE has state-of-the-art production facilities in the USA, Canada, Brazil, Germany, France and Switzerland. In addition, COLTENE has its own sales organizations in key markets such as Europe, North and Latin America, China and India. Dentists and dental laboratories around the world rely on COLTENE's high-quality products. The registered shares (CLTN) are traded on the SIX Swiss Exchange. Further information about COLTENE and its products can be found on the website www.coltene.com
This written statement and oral statements or other statements made, or to be made, by us contain forward-looking statements that do not relate solely to historical or current facts. These forward-looking statements are based on the current plans and expectations of our management and are subject to a number of uncertainties and risks that could significantly affect our current plans and expectations, as well as future results of operations and financial condition. We undertake no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.